147 related articles for article (PubMed ID: 38467644)
21. The Impact of Combined Radiation and Chemotherapy on Outcome in Uterine Clear Cell Carcinoma Compared with Chemotherapy Alone.
Mahdi H; Moulton L; Nutter B; Cherian S; Rose P
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):776-782. PubMed ID: 27339402
[TBL] [Abstract][Full Text] [Related]
22. Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study.
Kim M; Kwon BS; Chang HK; Lee S; Chang SJ; Choi JY; Park SY; Lee M; Ryu HS; Kim YB
J Gynecol Oncol; 2019 May; 30(3):e44. PubMed ID: 30887761
[TBL] [Abstract][Full Text] [Related]
23. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA
Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant chemotherapy in endometrial cancer.
Gómez-Raposo C; Merino Salvador M; Aguayo Zamora C; Casado Saenz E
Cancer Chemother Pharmacol; 2020 Mar; 85(3):477-486. PubMed ID: 31950214
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma. A multi-institutional study.
Mahdi H; Rose PG; Elshaikh MA; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; DeBenardo R
Gynecol Oncol; 2015 Mar; 136(3):529-33. PubMed ID: 25575483
[TBL] [Abstract][Full Text] [Related]
27. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
28. Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma.
Li S; Yi Z; Li M; Zhu Z
Sci Rep; 2023 Nov; 13(1):19883. PubMed ID: 37963944
[TBL] [Abstract][Full Text] [Related]
29. The Addition of Adjuvant Chemotherapy to Radiation in Early-Stage High-Risk Endometrial Cancer: Survival Outcomes and Patterns of Care.
Boothe D; Williams N; Odei B; Poppe MM; Werner TL; Suneja G; Gaffney DK
Int J Gynecol Cancer; 2017 Jun; 27(5):912-922. PubMed ID: 28498257
[TBL] [Abstract][Full Text] [Related]
30. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
Matei D; Filiaci V; Randall ME; Mutch D; Steinhoff MM; DiSilvestro PA; Moxley KM; Kim YM; Powell MA; O'Malley DM; Spirtos NM; Small W; Tewari KS; Richards WE; Nakayama J; Matulonis UA; Huang HQ; Miller DS
N Engl J Med; 2019 Jun; 380(24):2317-2326. PubMed ID: 31189035
[TBL] [Abstract][Full Text] [Related]
32. Toxicity after adjuvant therapy for stage III uterine cancer.
Chen LC; Huang Y; Hou JY; Khoury-Collado F; Melamed A; St Clair CM; Tergas AI; Hur C; Hillyer GC; Hershman DL; Wright JD
Gynecol Oncol; 2020 Dec; 159(3):737-743. PubMed ID: 33008633
[TBL] [Abstract][Full Text] [Related]
33. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
[TBL] [Abstract][Full Text] [Related]
34. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Chen L; Hu CS; Chen XZ; Hu GQ; Cheng ZB; Sun Y; Li WX; Chen YY; Xie FY; Liang SB; Chen Y; Xu TT; Li B; Long GX; Wang SY; Zheng BM; Guo Y; Sun Y; Mao YP; Tang LL; Chen YM; Liu MZ; Ma J
Lancet Oncol; 2012 Feb; 13(2):163-71. PubMed ID: 22154591
[TBL] [Abstract][Full Text] [Related]
35. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
[TBL] [Abstract][Full Text] [Related]
36. Uterine serous carcinoma: a historic evaluation of therapy.
de Leeuw Fa; Rijcken Fe; Trum Jw; van der Noort V; Tjon-Kon-Fat Ri; Bleeker Mc; Kenter Gg
Eur J Gynaecol Oncol; 2016; 37(2):211-5. PubMed ID: 27172747
[TBL] [Abstract][Full Text] [Related]
37. Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma.
Donkers H; Reijnen C; Galaal K; Lombaers MS; Snijders M; Kraayenbrink AA; Forrest J; Wilkinson R; Dubey S; Norris T; Bekkers R; Pijnenborg JMA; McGrane J
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e199-e205. PubMed ID: 36509615
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
39. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
40. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
